000			01779 a2200457 4500
005			20250515010615.0
264		0	_c20060503
008			200605s 0 0 eng d
022			_a0143-5221
024	7		_a10.1042/CS20050299 _2doi
040			_aNLM _beng _cNLM
100	1		_aSeko, Yoshinori
245	0	0	_aEffect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3. _h[electronic resource]
260			_bClinical science (London, England : 1979) _cMar 2006
300			_a379-86 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a8-Hydroxy-2'-Deoxyguanosine
650	0	4	_aAcute Disease
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCytokines _xmetabolism
650	0	4	_aDeoxyguanosine _xanalogs & derivatives
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEnterovirus B, Human _xisolation & purification
650	0	4	_aEnterovirus Infections _xphysiopathology
650	0	4	_aGenome, Viral
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHydralazine _xtherapeutic use
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C3H
650	0	4	_aMyocarditis _xphysiopathology
650	0	4	_aTetrazoles _xtherapeutic use
650	0	4	_aVasodilator Agents _xtherapeutic use
773	0		_tClinical science (London, England : 1979) _gvol. 110 _gno. 3 _gp. 379-86
856	4	0	_uhttps://doi.org/10.1042/CS20050299 _zAvailable from publisher's website
999			_c15957475 _d15957475